Hans K. Erickson

3.1k total citations
43 papers, 2.1k citations indexed

About

Hans K. Erickson is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Hans K. Erickson has authored 43 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Radiology, Nuclear Medicine and Imaging, 30 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Hans K. Erickson's work include Monoclonal and Polyclonal Antibodies Research (30 papers), HER2/EGFR in Cancer Research (28 papers) and Nanofabrication and Lithography Techniques (6 papers). Hans K. Erickson is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (30 papers), HER2/EGFR in Cancer Research (28 papers) and Nanofabrication and Lithography Techniques (6 papers). Hans K. Erickson collaborates with scholars based in United States, France and United Kingdom. Hans K. Erickson's co-authors include Wayne C. Widdison, C. Dale Poulter, Yelena Kovtun, John M. Lambert, Robert J. Lutz, Victor S. Goldmacher, Hirekodathakallu V. Thulasiram, Charlene A. Audette, Rajeeva Singh and Peter U. Park and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Hans K. Erickson

42 papers receiving 2.0k citations

Peers

Hans K. Erickson

ONCOL

RNMI

IMMUN

Nicole M. Okeley United States

Wayne C. Widdison United States

Frank Loganzo United States

Toshinori Agatsuma Japan

Philip R. Hamann United States

Brian A. Mendelsohn United States

Patrick Burke United States

Sharon Wilhelm United States

Rajeeva Singh United States

Alan Berezov United States

Nicole M. Okeley United States

Hans K. Erickson

1.4k ×1.1

ONCOL

1.4k ×1.1

RNMI

1.2k ×1.5

443 ×2.1

316 ×1.9

IMMUN

Citations per year, relative to Hans K. Erickson Hans K. Erickson (= 1×) peers Nicole M. Okeley

Countries citing papers authored by Hans K. Erickson

Since Specialization

Citations

This map shows the geographic impact of Hans K. Erickson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans K. Erickson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans K. Erickson more than expected).

Fields of papers citing papers by Hans K. Erickson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans K. Erickson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans K. Erickson. The network helps show where Hans K. Erickson may publish in the future.

Co-authorship network of co-authors of Hans K. Erickson

This figure shows the co-authorship network connecting the top 25 collaborators of Hans K. Erickson. A scholar is included among the top collaborators of Hans K. Erickson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans K. Erickson. Hans K. Erickson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Klerman, Elizabeth B., et al.. (2022). Relationships of self-reported and objective measures of sleep, sleepiness, and sleep quality in Parkinson's disease. Parkinsonism & Related Disorders. 101. 57–61. 7 indexed citations

Yoder, Nicholas C., Chen Bai, Wayne C. Widdison, et al.. (2019). A Case Study Comparing Heterogeneous Lysine- and Site-Specific Cysteine-Conjugated Maytansinoid Antibody-Drug Conjugates (ADCs) Illustrates the Benefits of Lysine Conjugation. Molecular Pharmaceutics. 16(9). 3926–3937. 30 indexed citations

Vollmar, Breanna S., BinQing Wei, Rachana Ohri, et al.. (2017). Attachment Site Cysteine Thiol pK_a Is a Key Driver for Site-Dependent Stability of THIOMAB Antibody–Drug Conjugates. Bioconjugate Chemistry. 28(10). 2538–2548. 26 indexed citations

Mateen, Farrah J., et al.. (2017). Light therapy for multiple sclerosis-associated fatigue. Medicine. 96(36). e8037–e8037. 9 indexed citations

Zhang, Dawei, Shang‐Fan Yu, Yong Ma, et al.. (2016). Chemical Structure and Concentration of Intratumor Catabolites Determine Efficacy of Antibody Drug Conjugates. Drug Metabolism and Disposition. 44(9). 1517–1523. 21 indexed citations

Bialucha, Carl Uli, Kathy L. Miller, Stuart W. Hicks, et al.. (2016). Microscale screening of antibody libraries as maytansinoid antibody-drug conjugates. mAbs. 8(3). 513–523. 17 indexed citations

Hong, Erica, Hans K. Erickson, Robert J. Lutz, et al.. (2015). Design of Coltuximab Ravtansine, a CD19-Targeting Antibody–Drug Conjugate (ADC) for the Treatment of B-Cell Malignancies: Structure–Activity Relationships and Preclinical Evaluation. Molecular Pharmaceutics. 12(6). 1703–1716. 38 indexed citations

Erickson, Hans K., Gail D. Lewis Phillips, Douglas D. Leipold, et al.. (2014). Mechanistic pharmacokinetic/pharmacodynamic modeling of in vivo tumor uptake, catabolism, and tumor response of trastuzumab maytansinoid conjugates. Cancer Chemotherapy and Pharmacology. 74(5). 969–980. 22 indexed citations

Bilic, Sanela, Douglas D. Leipold, William Mallet, et al.. (2013). American Association of Pharmaceutical Scientists National Biotechnology Conference Short Course: Translational Challenges in Developing Antibody-Drug Conjugates. mAbs. 5(1). 5–12. 10 indexed citations

10.

Ponte, Jose F., Xiuxia Sun, Nicholas C. Yoder, et al.. (2013). Abstract 5677: The anti-EGFR ADC, IMGN289 displays favorable pharmacokinetic properties.. Cancer Research. 73(8_Supplement). 5677–5677. 1 indexed citations

11.

Erickson, Hans K., Gail D. Lewis Phillips, Douglas D. Leipold, et al.. (2012). The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics/Pharmacodynamics of Trastuzumab Maytansinoid Conjugates. Molecular Cancer Therapeutics. 11(5). 1133–1142. 141 indexed citations

12.

Sun, Xiuxia, Lauren Clancy, Kathleen R. Whiteman, et al.. (2011). Abstract B195: Lorvotuzumab mertansine displays favorable pharmacokinetics and tumor delivery in mouse models.. Molecular Cancer Therapeutics. 10(11_Supplement). B195–B195. 1 indexed citations

13.

Kovtun, Yelena, Charlene A. Audette, Michele Mayo, et al.. (2010). Antibody-Maytansinoid Conjugates Designed to Bypass Multidrug Resistance. Cancer Research. 70(6). 2528–2537. 194 indexed citations

14.

Erickson, Hans K., Sharon Wilhelm, Wayne C. Widdison, et al.. (2008). Evaluation of the cytotoxic potencies of the major maytansinoid metabolites of antibody maytansinoid conjugates detected in vitro and in preclinical mouse models. Cancer Research. 68. 2150–2150. 4 indexed citations

15.

Singh, Rajeeva & Hans K. Erickson. (2008). Antibody–Cytotoxic Agent Conjugates: Preparation and Characterization. Methods in molecular biology. 525. 445–467. 30 indexed citations

16.

Thulasiram, Hirekodathakallu V., Hans K. Erickson, & C. Dale Poulter. (2008). A Common Mechanism for Branching, Cyclopropanation, and Cyclobutanation Reactions in the Isoprenoid Biosynthetic Pathway. Journal of the American Chemical Society. 130(6). 1966–1971. 41 indexed citations

17.

Erickson, Hans K., Michele Mayo, Wayne C. Widdison, et al.. (2007). Linker selection in antibody-maytansinoid conjugates impacts bystander killing in mouse xenograft models. Molecular Cancer Therapeutics. 6. 1 indexed citations

18.

Erickson, Hans K., Peter U. Park, Wayne C. Widdison, et al.. (2006). Antibody-Maytansinoid Conjugates Are Activated in Targeted Cancer Cells by Lysosomal Degradation and Linker-Dependent Intracellular Processing. Cancer Research. 66(8). 4426–4433. 421 indexed citations

19.

Hemmerlin, Andréa, Susan B. Rivera, Hans K. Erickson, & C. Dale Poulter. (2003). Enzymes Encoded by the Farnesyl Diphosphate Synthase Gene Family in the Big Sagebrush Artemisia tridentata ssp. spiciformis. Journal of Biological Chemistry. 278(34). 32132–32140. 79 indexed citations

20.

Erickson, Hans K.. (2000). Formation of the Cystine between Cysteine 225 and Cysteine 462 from Ribonucleoside Diphosphate Reductase Is Kinetically Competent. Biochemistry. 39(31). 9241–9250. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact